| 000 | 01697 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517200535.0 | ||
| 264 | 0 | _c20191118 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a1538-9375 | ||
| 024 | 7 |
_a10.1016/j.jamda.2017.12.098 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeppala, Lotta J | |
| 245 | 0 | 0 |
_aFall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics. _h[electronic resource] |
| 260 |
_bJournal of the American Medical Directors Association _c04 2018 |
||
| 300 |
_a371.e11-371.e17 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review | ||
| 650 | 0 | 4 |
_aAccidental Falls _xstatistics & numerical data |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntidepressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBenzodiazepines _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGeriatric Assessment |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNetherlands |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aPsychotropic Drugs _xadverse effects |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSex Factors |
| 700 | 1 | _aWermelink, Anne M A T | |
| 700 | 1 | _ade Vries, Max | |
| 700 | 1 | _aPloegmakers, Kimberley J | |
| 700 | 1 | _avan de Glind, Esther M M | |
| 700 | 1 | _aDaams, Joost G | |
| 700 | 1 | _avan der Velde, Nathalie | |
| 773 | 0 |
_tJournal of the American Medical Directors Association _gvol. 19 _gno. 4 _gp. 371.e11-371.e17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jamda.2017.12.098 _zAvailable from publisher's website |
| 999 |
_c28046072 _d28046072 |
||